echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Sorafeini's first imitation hanging net price of 3990 yuan / box is 70% of the original research price

    Sorafeini's first imitation hanging net price of 3990 yuan / box is 70% of the original research price

    • Last Update: 2020-10-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 1st, the Inner Mongolia Autonomous Region Pharmaceuticals Centralized Procurement Network issued a notice that Jiangxi Shanxiang Pharmaceutical Cobenzene Sulfini tablets (specs: 0.2g x 60 tablets) were given a supplementary hanging net at a purchase price of 3990.00 yuan/box, which was officially implemented on September 5, 2020.
    Sorafenib was developed by Bayer and approved in September 2006 for the treatment of kidney cancer (trade name: Dojime), followed by the treatment of hepatocellular carcinoma, local late stage or metastatic radioactive iodine (RAI) refragtic differentiated thyroid cancer.
    Sorapini successfully entered health care in the 2017 health care negotiations, and the 2019 health insurance expiration follow-up negotiations again cut the price of health insurance, data show that Sorrapini's 2019 health care negotiations after the price of 95 yuan / piece (0.2g), a box (spec: 0.2g x 60 pieces) of the price of about 5700 yuan.
    the original research in China after 14 years, domestic generic drugs were finally approved.
    August 7, 2020, Jiangxi Shanxiang Pharmaceuticals 4 generic drugs were approved, the first generic in China, the current online price is about 70% of the original research;
    The Policy Interpretation of the Notice on the Inclusion of Negotiated Drugs in the National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog for 2019 issued by the State Administration of Health Insurance clearly states that generic drugs automatically fall into the medical insurance catalogue after approval during the validity period of the negotiated drugs, and that the generic drug shall be included in the centralized procurement scope, and the medical insurance department will adjust the payment standards of the generic drug according to the price level of the generic drug.
    so that Solafeini generics automatically enter health insurance, its pricing will be a reference to the generic drug Medicare payment standard adjustments.
    has grown significantly since it was included in Medicare in 2017, with public data showing that domestic public health service sales have exceeded $1 billion in 2018.
    with the approval of generic drugs, the price of sorapinie will be further lowered, but also face the huge risk of being collected.
    domestic generic drug companies take advantage of the next batch of collection before the arrival of rapid paving, perhaps can also earn a recovery of part of the cost.
    original title: Sorafeini first imitation hanging net price of 3990 yuan / box, 70% of the original research price
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.